GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.42X leverage
Performance
- Low
- ₹1,962
- High
- ₹2,023
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,000
- Previous Close₹1,997
- Volume424,174
- 50 DMA₹1,979.41
- 100 DMA₹1,944.46
- 200 DMA₹1,849.43
Investment Returns
- Over 1 Month -3.87%
- Over 3 Month + 6.33%
- Over 6 Month -8%
- Over 1 Year + 30.23%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 55
- PEG Ratio
- 0.3
- Market Cap Cr
- 55,529
- P/B Ratio
- 5.8
- Average True Range
- 50.02
- EPS
- 89.11
- Dividend Yield
- 0.3
- MACD Signal
- 8.84
- RSI
- 45.72
- MFI
- 44.89
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,967.70
-29.5
(-1.48%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹1,997.76
- 50 Day
- ₹1,979.41
- 100 Day
- ₹1,944.46
- 200 Day
- ₹1,849.43
Resistance and Support
1984.13
- R3 2,067.57
- R2 2,045.23
- R1 2,006.47
- S1 1,945.37
- S2 1,923.03
- S3 1,884.27
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,967 As on 24 January, 2026 | 11:29
The Market Cap of Glenmark Pharmaceuticals is ₹55528.7 Cr As on 24 January, 2026 | 11:29
The P/E ratio of Glenmark Pharmaceuticals is 55 As on 24 January, 2026 | 11:29
The PB ratio of Glenmark Pharmaceuticals is 5.8 As on 24 January, 2026 | 11:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.